KING OF PRUSSIA, Pa., Aug. 15, 2024 /PRNewswire/ -- Universal Health Services, Inc. (NYSE: UHS) announced today that Steve Filton, Executive Vice President and Chief Financial Officer will present at the following conferences:
Friday, September 6, 2024, at 9:30am (ET) at the 2024 Wells Fargo Healthcare Conference in Boston, Massachusetts
Wednesday, September 11, 2024, at 9:05am (ET) at the Baird 2024 Global Healthcare Conference in New York, New York
Live audio webcasts of the presentations will be available on the Company's website (www.uhs.com). For those unable to listen to the live webcast, replays of the presentations will be available on the Company's website for 90 days following the conferences.
Universal Health Services, Inc. ("UHS") is one of the nation's largest providers of hospital and healthcare services. Through its subsidiaries, UHS operates acute care hospitals, behavioral health facilities, outpatient facilities and ambulatory care access points located throughout the United States, Puerto Rico and the United Kingdom.
| Last Trade: | US$196.72 |
| Daily Change: | -0.80 -0.41 |
| Daily Volume: | 429,403 |
| Market Cap: | US$11.550B |
October 29, 2024 June 07, 2024 | |
C4 Therapeutics is pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins via degradation using the innate machinery of the cell. This targeted protein degradation approach offers advantages over traditional drugs, including the potential to treat a wider range of diseases...
CLICK TO LEARN MORE
Immix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...
CLICK TO LEARN MORE
